• 1789 Citations
  • 18 h-Index
19962020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

  • 1789 Citations
  • 18 h-Index
  • 18 Article
  • 4 Review article
  • 2 Chapter
  • 1 Short survey
2020

ADP-ribosylation levels and patterns correlate with gene expression and clinical outcomes in ovarian cancers

Conrad, L. B., Lin, K. Y., Nandu, T., Gibson, B. A., Lea, J. S. & Lee Kraus, W., 2020, In : Molecular cancer therapeutics. 19, 1, p. 282-291 10 p.

Research output: Contribution to journalArticle

2 Scopus citations

Long noncoding RNAs in cancer: From discovery to therapeutic targets

Choudhari, R., Sedano, M. J., Harrison, A. L., Subramani, R., Lin, K. Y., Ramos, E. I., Lakshmanaswamy, R. & Gadad, S. S., 2020, Advances in Clinical Chemistry. Makowski, G. S. (ed.). Academic Press Inc., p. 105-147 43 p. (Advances in Clinical Chemistry; vol. 95).

Research output: Chapter in Book/Report/Conference proceedingChapter

4 Scopus citations
2018

Generating protein-linked and protein-free mono-, oligo-, and poly(ADP-ribose) in vitro

Lin, K. Y., Huang, D. & Lee Kraus, W., 2018, Methods in Molecular Biology. Humana Press Inc., p. 91-108 18 p. (Methods in Molecular Biology; vol. 1813).

Research output: Chapter in Book/Report/Conference proceedingChapter

2017

Dual-targeting nanoparticles for in vivo delivery of suicide genes to chemotherapy-resistant ovarian cancer cells

Cocco, E., Deng, Y., Shapiro, E. M., Bortolomai, I., Lopez, S., Lin, K. Y., Bellone, S., Cui, J., Menderes, G., Black, J. D., Schwab, C. L., Bonazzoli, E., Yang, F., Predolini, F., Zammataro, L., Altwerger, G., De Haydu, C., Clark, M., Alvarenga, J., Ratner, E. & 6 others, Azodi, M., Silasi, D. A., Schwartz, P. E., Litkouhi, B., Saltzman, W. M. & Santin, A. D., Feb 1 2017, In : Molecular Cancer Therapeutics. 16, 2, p. 323-333 11 p.

Research output: Contribution to journalArticle

18 Scopus citations

PARP Inhibitors for Cancer Therapy

Lin, K. Y. & Kraus, W. L., Apr 6 2017, In : Cell. 169, 2, 1 p.

Research output: Contribution to journalShort survey

41 Scopus citations
2016

Efficacy and tolerability of combination cisplatin and ifosfamide chemotherapy with vaginal cuff brachytherapy in the first line treatment of uterine carcinosarcoma

Abu-Khalaf, M. M., Raza, M. A., Hatzis, C., Wang, H., Lin, K., Higgins, S., Ratner, E., Silasi, D. A., Azodi, M., Rutherford, T. J., Santin, A. D. & Schwartz, P. E., Jan 1 2016, In : European Journal of Gynaecological Oncology. 37, 2, p. 199-203 5 p.

Research output: Contribution to journalArticle

Risk of Occult Uterine Sarcoma in Women Undergoing Hysterectomy for Benign Indications

Kho, K. A., Lin, K., Hechanova, M. & Richardson, D. L., Mar 1 2016, In : Obstetrics and gynecology. 127, 3, p. 468-473 6 p.

Research output: Contribution to journalArticle

33 Scopus citations
2015

Ovarian involvement in endometrioid adenocarcinoma of uterus

Lin, K. Y., Miller, D. S., Bailey, A. A., Andrews, S. J., Kehoe, S. M., Richardson, D. L. & Lea, J. S., Sep 1 2015, In : Gynecologic Oncology. 138, 3, p. 532-535 4 p.

Research output: Contribution to journalArticle

20 Scopus citations
2014

Malignant ovarian germ cell tumor - Role of surgical staging and gonadal dysgenesis

Lin, K. Y., Bryant, S., Miller, D. S., Kehoe, S. M., Richardson, D. L. & Lea, J. S., Jul 2014, In : Gynecologic Oncology. 134, 1, p. 84-89 6 p.

Research output: Contribution to journalArticle

24 Scopus citations
2012

Cervical Cancer

Lea, J. S. & Lin, K. Y., Jun 1 2012, In : Obstetrics and Gynecology Clinics of North America. 39, 2, p. 233-253 21 p.

Research output: Contribution to journalReview article

28 Scopus citations
2011

Her2/neu extracellular domain shedding in uterine serous carcinoma: Implications for immunotherapy with trastuzumab

Todeschini, P., Cocco, E., Bellone, S., Varughese, J., Lin, K., Carrara, L., Guzzo, F., Buza, N., Hui, P., Silasi, D. A., Ratner, E., Azodi, M., Schwartz, P. E., Rutherford, T. J., Pecorelli, S. & Santin, A. D., Oct 11 2011, In : British Journal of Cancer. 105, 8, p. 1176-1182 7 p.

Research output: Contribution to journalArticle

25 Scopus citations

Tissue factor expression in ovarian cancer: Implications for immunotherapy with hI-con1, a factor VII-IgGF c chimeric protein targeting tissue factor

Cocco, E., Varughese, J., Buza, N., Bellone, S., Lin, K. Y., Bellone, M., Todeschini, P., Silasi, D. A., Azodi, M., Schwartz, P. E., Rutherford, T. J., Carrara, L., Tassi, R., Pecorelli, S., Lockwood, C. J. & Santin, A. D., Oct 2011, In : Clinical and Experimental Metastasis. 28, 7, p. 689-700 12 p.

Research output: Contribution to journalArticle

18 Scopus citations
2010

Ectopic expression of X-linked lymphocyte-regulated protein pM1 renders tumor cells resistant to antitumor immunity

Kang, T. H., Noh, K. H., Kim, J. H., Bae, H. C., Lin, K. Y., Monie, A., Pai, S. I., Hung, C. F., Wu, T. C. & Kim, T. W., Apr 15 2010, In : Cancer Research. 70, 8, p. 3062-3070 9 p.

Research output: Contribution to journalArticle

16 Scopus citations

Perspectives for Preventive and Therapeutic HPV Vaccines

Lin, K., Doolan, K., Hung, C. F. & Wu, T. C., Jan 2010, In : Journal of the Formosan Medical Association. 109, 1, p. 4-24 21 p.

Research output: Contribution to journalReview article

57 Scopus citations

Therapeutic HPV DNA vaccines

Lin, K., Roosinovich, E., Ma, B., Hung, C. F. & Wu, T. C., Jul 1 2010, In : Immunologic Research. 47, 1-3, p. 86-112 27 p.

Research output: Contribution to journalReview article

82 Scopus citations
2009

Activation of Akt as a mechanism for tumor immune evasion

Noh, K. H., Kang, T. H., Kim, J. H., Pai, S. I., Lin, K. Y., Hung, C. F., Wu, T. C. & Kim, T. W., Jan 1 2009, In : Molecular Therapy. 17, 3, p. 439-447 9 p.

Research output: Contribution to journalArticle

62 Scopus citations
2007

Ectopic expression of vascular cell adhesion molecule-1 as a new mechanism for tumor immune evasion

Lin, K. Y., Lu, D., Hung, C. F., Peng, S., Huang, L., Jie, C., Murillo, F., Rowley, J., Tsai, Y. C., He, L., Kim, D. J., Jaffee, E., Pardoll, D. & Wu, T. C., Feb 15 2007, In : Cancer Research. 67, 4, p. 1832-1841 10 p.

Research output: Contribution to journalArticle

56 Scopus citations
2004

Human papillomavirus type-16 virus-like particles activate complementary defense responses in key dendritic cell subpopulations

Yang, R., Murillo, F. M., Lin, K. Y., Yutzy IV, W. H., Uematsu, S., Takeda, K., Akira, S., Viscidi, R. P. & Roden, R. B. S., Aug 15 2004, In : Journal of Immunology. 173, 4, p. 2624-2631 8 p.

Research output: Contribution to journalArticle

15 Scopus citations
2003

Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies and antitumor effects of HPV-16 E7-expressing sindbis virus replicon particles

Lin, C. T., Hung, C. F., Juang, J., He, L., Lin, K. Y., Kim, T. W. & Wu, T. C., Oct 2003, In : Molecular Therapy. 8, 4, p. 559-566 8 p.

Research output: Contribution to journalArticle

42 Scopus citations

CD8+ T cells, NK cells and IFN-γ are important for control of tumor with downregulated MHC class I expression by DNA vaccination

Cheng, W. F., Hung, C. F., Lin, K. Y., Ling, M., Juang, J., He, L., Lin, C. T. & Wu, T. C., Aug 1 2003, In : Gene Therapy. 10, 16, p. 1311-1320 10 p.

Research output: Contribution to journalReview article

50 Scopus citations

Cell surface-binding motifs of L2 that facilitate papillomavirus infection

Yang, R., Day, P. M., Yutzy IV, W. H., Lin, K. Y., Hung, C. F. & Roden, R. B. S., Mar 1 2003, In : Journal of virology. 77, 6, p. 3531-3541 11 p.

Research output: Contribution to journalArticle

76 Scopus citations
1999

Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors

Ji, H., Wang, T. L., Chen, C. H., Pai, S. I., Hung, C. F., Lin, K. Y., Kurman, R. J., Pardoll, D. M. & Wu, T. C., Nov 20 1999, In : Human Gene Therapy. 10, 17, p. 2727-2740 14 p.

Research output: Contribution to journalArticle

209 Scopus citations
1998

Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein

Ji, H., Chang, E. Y., Lin, K. Y., Kurman, R. J., Pardoll, D. M. & Wu, T. C., Sep 3 1998, In : International Journal of Cancer. 78, 1, p. 41-45 5 p.

Research output: Contribution to journalArticle

113 Scopus citations
1997

Coinfection of HPV-11 and HPV-16 in a case of laryngeal squamous papillomas with severe dysplasia

Lin, K. Y., Westra, W. H., Kashima, H. K., Mounts, P. & Wu, T. C., Jul 1 1997, In : Laryngoscope. 107, 7, p. 942-947 6 p.

Research output: Contribution to journalArticle

21 Scopus citations
1996

Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen

Lin, K. Y., Guarnieri, F. G., Staveley-O'Carroll, K. F., Levitsky, H. I., August, J. T., Pardoll, D. M. & Wu, T. C., Jan 1 1996, In : Cancer Research. 56, 1, p. 21-26 6 p.

Research output: Contribution to journalArticle

777 Scopus citations